Ignite Creation Date:
2025-12-24 @ 11:30 PM
Ignite Modification Date:
2025-12-25 @ 9:17 PM
Study NCT ID:
NCT00574756
Status:
TERMINATED
Last Update Posted:
2019-08-02
First Post:
2007-12-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
Sponsor:
University of California, San Diego
Organization:
Study Overview
Official Title:
The Effect of Ranolazine on Echocardiographic Indices of Diastolic Dysfunction
Status:
TERMINATED
Status Verified Date:
2019-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
no funding
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the effects of ranolazine, an FDA-approved medication for the treatment of angina, on heart function by using echocardiography.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?: